X4 Pharmaceuticals
XFOR
XFOR
56 hedge funds and large institutions have $28.7M invested in X4 Pharmaceuticals in 2022 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 13 increasing their positions, 16 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
15% less call options, than puts
Call options by funds: $748K | Put options by funds: $878K
19% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 16
29% less capital invested
Capital invested by funds: $40.2M → $28.7M (-$11.5M)
Holders
56
Holding in Top 10
1
Calls
$748K
Puts
$878K
Top Buyers
| 1 | +$353K | |
| 2 | +$246K | |
| 3 | +$243K | |
| 4 |
BCLSI
Bain Capital Life Sciences Investors
Boston,
Massachusetts
|
+$233K |
| 5 |
Stifel Financial
St. Louis,
Missouri
|
+$122K |
Top Sellers
| 1 | -$1.56M | |
| 2 | -$816K | |
| 3 | -$490K | |
| 4 |
BFM
Boothbay Fund Management
New York
|
-$171K |
| 5 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
-$158K |